Fertility preservation in women with breast cancer

Clinical Obstetrics and Gynecology

Volumn 53, Issue 4, 2010, Pages 753-762

  Rodriguez Wallberg, Kenny A ^a,b   Oktay, Kutluk ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

aromatase inhibitors; breast cancer; cryopreservation; female; fertility preservation

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTRADIOL; FLUOROURACIL; GONADORELIN AGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; METHOTREXATE; RECOMBINANT FOLLITROPIN; TAMOXIFEN;

AMENORRHEA; BREAST CANCER; CANCER PATIENT; CANCER SUSCEPTIBILITY; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; DRUG SAFETY; FEMALE FERTILITY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; INFERTILITY; NONHUMAN; ONCOGENE; OVARY FOLLICLE; OVARY INSUFFICIENCY; PATIENT COUNSELING; PREGNANCY; PRESERVATION; REVIEW; TERATOGENICITY;

AROMATASE INHIBITORS; BREAST NEOPLASMS; COUNSELING; CRYOPRESERVATION; EMBRYO, MAMMALIAN; FEMALE; FERTILITY; GONADOTROPINS; HETEROZYGOTE; HUMANS; INFERTILITY, FEMALE; NITRILES; OOCYTES; OVULATION INDUCTION; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TRIAZOLES;

EID: 78349267185     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181f96e00     Document Type: Review

References (34)

1. SEER Cancer Statistics Review, 1975- 2006, National Cancer Institute. Bethesda, MD, based on November 2008 SEER data submission. Available at http://seer.cancer. gov/statfacts/html/breast.html. [Accessed August 11, 2009]
2. Schover LR, Rybicki LA, Martin BA, et al. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer. 1999;86:697-709.
3. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. American Society of Clinical Oncology. J Clin Oncol. 2006;24:2917-2931.
4. Duffy CM, Allen SM, Clark MA. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol. 2005;23:766-773.
5. Gadducci A, Cosio S, Genazzani AR. Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endo-crinol. 2007;23:625-631; Review.
6. Hortobagyi GN, Buzdar AU, Marcus CE, et al. Immediate and long-term toxi-city of adjuvant chemotherapy regimens containing doxorubicin in trials at MD Anderson Hospital and Tumor Institute. NCI Monogr. 1986;1:105-109.
7. Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist. 2006; 11:422-434; Review.
8. Hickley M, Peate M, Saunders CM, et al. Breast cancer in young women and its impact on reproductive function. Hum Reprod Update. 2009;15:323-339.
9. Kotsopoulos J, Librach CL, Lubinski J, et al; Hereditary Breast Cancer Clinical Study Group. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Cancer Causes Control. 2008;19:1111-1119.
10. Oktay K, Kim JY, Barad D, et al. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28:240-244. [Epub December 7, 2009]
11. Kroman N, Jensen MB, Wohlfahrt J, et al; Danish Breast Cancer Cooperative Group. Pregnancy after treatment of breast cancer a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol. 2008;47: 545-549.
12. Marrs RP, Greene J, Stone BA. Potential factors affecting embryo survival and clinical outcome with cryopreserved pro-nuclear human embryos. Am J Obstet Gynecol. 2004;190:1766-1771.
13. Wallberg KA, Keros V, Hovatta O. Clinical aspects of fertility preservation in female patients. Pediatr Blood Cancer. 2009;53:254-260.
14. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009; 18:769-776.
15. Chian RC, Huang JY, Gilbert L, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91:2391-2398.
16. Oktay K, Buyuk E. Ovarian transplantation in humans: indications, techniques and the risk of reseeding cancer. Eur J Obstet Gynecol Reprod Biol. 2004;113 (suppl 1):S45-S47; Review.
17. Oktay K, Oktem O. Ovarian cryopreser-vation and transplantation for fertility preservation for medical indications: report of an ongoing experience. Fertil Steril. 2010;93:762-768.
18. Sanchez-Serrano M, Novella-Maestre E, Rosello-Sastre E, et al. Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum Re-prod. 2009;24:2238-2243.
19. Azem F, Hasson J, Ben-Yosef D, et al. Histologic evaluation of fresh human ovarian tissue before cryopreservation. Int J Gynecol Pathol. 2010;29:19-23.
20. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet. 1992;339:71-85.
21. Oktay K, Buyuk E, Davis O, et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod. 2003;18:90-95.
22. Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347-4353.
23. Fisk NM, Templeton AA, Papadopoulos GC, et al. Lack of effect of high-dose antioestrogen on the maturation and in-vitro fertilization of human oocytes. Hum Reprod. 1989;4:584-587.
24. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovu-lation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75:305-309.
25. Polyzos NP, Tzioras S, Badawy AM, et al. Aromatase inhibitors for female infertility: a systematic review of the literature. Reprod Biomed Online. 2009;19:456-471; Review.
26. Fisher SA, Reid RL, Van Vugt DA, et al. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovu-latory function in normal women. Fertil Steril. 2002;78:280-285.
27. Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonado-tropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91:3885-3890.
28. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26:2630-2635.
29. Azim AA, Costantini-Ferrando M, Los-tritto K, et al. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab. 2007;92:2197-2200.
30. Oktay K, Turkcuoglu I, Rodriguez-Wall-berg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhi-bitor/FSH stimulation. Reprod Biomed Online. 2010;20:783-788.
31. Oktay K, Buyuk E, Rodriguez-Wallberg KA, et al. IVM improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online. 2010;20: 634-638.
32. Cold S, During M, Ewertz M, et al. Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG). Br J Cancer. 2005;93:627-632.
33. Lohrisch C, Paltiel C, Gelmon K, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2006;24:4888-4894.
34. Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006;85:1761-1765.